EUVIMEDEUVIMED entdecken
Crossref

Optimizing Bispecific Antibody Expression via Multi‐Omics Analysis and Vector Redesign

Jeremy J Gam, Michelle M Chang, Dinghai Zheng, Jennitte Stevens, Alec A K Nielsen, Kevin D Smith

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Jeremy J Gam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Asimov, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Protein Engineering, Genetic Vectors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bispecific antibodies are a growing class of therapeutics that simultaneously engage two targets. However, their complex molecular structures pose challenges for production in Chinese hamster ovary cells, the current industry standard for biologics manufacturing. Here we present a case study of three IgG‐scFv format bsAbs expressed in CHO cells, in which one candidate exhibited markedly lower titers despite high sequence homology to the other two. Using multi‐omics analysis (RNA sequencing, splicing prediction, codon optimization assessment, and motif screening) to investigate potential causes, we identified several likely mechanisms for poor expression, including aberrant splicing motifs, ribosome pausing sites, and suboptimal codon usage. Through targeted protein and DNA sequence engineering, we generated a revised variant with an 11‐fold increase in stable expression titers. This work demonstrates that integrating sequence‐level bioinformatic and synthetic biology diagnostics can directly improve manufacturability, providing a generalizable framework for resolving hidden expression liabilities in complex biologics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificProtein EngineeringGenetic VectorsAnimalsCHO CellsCricetulusMultiomicsSingle-Chain AntibodiesRecombinant Proteins

Stichwörter der Autor:innen

CHO expressionbiotherapeutic developmentbispecific antibodiescodon optimizationmulti‐omics analysisribosome pausingvector engineering

Substanzen

Antibodies, BispecificSingle-Chain AntibodiesRecombinant Proteins

Autor:innen und Institutionen

  • Asimov, Boston, Massachusetts, USA.
  • Amgen, One Amgen Center Drive, Thousand Oaks, California, USA.

Zitieren

APA

Gam, J. J., Chang, M. M., Zheng, D., Stevens, J., Nielsen, A. A. K., & Smith, K. D. (2026). Optimizing Bispecific Antibody Expression via Multi‐Omics Analysis and Vector Redesign. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70228

Vancouver

Gam JJ, Chang MM, Zheng D, Stevens J, Nielsen AAK, Smith KD. Optimizing Bispecific Antibody Expression via Multi‐Omics Analysis and Vector Redesign. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70228

BibTeX
@article{Gam2026,
  author = {Gam, Jeremy J and Chang, Michelle M and Zheng, Dinghai and Stevens, Jennitte and Nielsen, Alec A K and Smith, Kevin D},
  title = {Optimizing Bispecific Antibody Expression via Multi‐Omics Analysis and Vector Redesign},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70228}
}
Kostenlos starten →